These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 9366699

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [The species composition and sensitivity of pathogenic microflora responsible for the development of otitis externa diffusa to the components of Polidexa].
    Krasnozhen VN, Pokrovskaya EM, Bayazitova LT.
    Vestn Otorinolaringol; 2018; 83(1):65-67. PubMed ID: 29488502
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Treatment of chronic suppurative otitis media with topical ciprofloxacin.
    Dohar JE, Alper CM, Rose EA, Doyle WJ, Casselbrant ML, Kenna MA, Bluestone CD.
    Ann Otol Rhinol Laryngol; 1998 Oct; 107(10 Pt 1):865-71. PubMed ID: 9794617
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A benefit-risk assessment of ofloxacin otic solution in ear infection.
    Wai TK, Tong MC.
    Drug Saf; 2003 Oct; 26(6):405-20. PubMed ID: 12688832
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot GH.
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A randomized, controlled, single-blinded, multicenter evaluation of the efficacy and safety of a once weekly two dose otic gel containing florfenicol, terbinafine and betamethasone administered for the treatment of canine otitis externa.
    King SB, Doucette KP, Seewald W, Forster SL.
    BMC Vet Res; 2018 Oct 11; 14(1):307. PubMed ID: 30305092
    [Abstract] [Full Text] [Related]

  • 36. A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis.
    Wadsten CJ, Bertilsson CA, Sieradzki H, Edström S.
    Arch Otorhinolaryngol; 1985 Oct 11; 242(2):135-9. PubMed ID: 2415098
    [Abstract] [Full Text] [Related]

  • 37. Controlled multicenter study on chronic suppurative otitis media treated with topical applications of ciprofloxacin 0.2% solution in single-dose containers or combination of polymyxin B, neomycin, and hydrocortisone suspension.
    Miró N.
    Otolaryngol Head Neck Surg; 2000 Nov 11; 123(5):617-23. PubMed ID: 11077352
    [Abstract] [Full Text] [Related]

  • 38. Comparative efficacy and tolerability of two antibacterial/anti-inflammatory formulations ('Otomize' spray and 'Otosporin' drops) in the treatment of otitis externa in general practice.
    Smith RB, Moodie J.
    Curr Med Res Opin; 1990 Nov 11; 11(10):661-7. PubMed ID: 2155756
    [Abstract] [Full Text] [Related]

  • 39. Oral ofloxacin therapy for invasive external otitis.
    Zikk D, Rapoport Y, Redianu C, Shalit I, Himmelfarb MZ.
    Ann Otol Rhinol Laryngol; 1991 Aug 11; 100(8):632-7. PubMed ID: 1908200
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.